OvaCure at the summit "Measuring The Success And Impact Of Ovarian Cancer Nonprofit Research Funding"

OvaCure accelerates clinical research on ovarian cancer through collaboration, co-creation and knowledge sharing. Therefore it was a honour for OvaCure to present at the summit "Measuring The Success And Impact Of Ovarian Cancer Nonprofit Research Funding" during the 12th Biennial Ovarian Cancer Research Symposium in Seattle this year.

For us this has been a precious occasion to bring up the challenges of organizations like OvaCure and to discuss possible solutions with patients, organizations and scientists.

The participants have shown deep interest in OvaCure and its projects, especially in the projects of T-cell Infusion, CAR-T Cell and Tumour-Match. We thank all the participants and we will treasure all the constructive feedback, insights and new knowledge gathered during the event. 

Ovacure- curing ovarian cancer together!

OvaCure presents at the 12th Biennial Ovarian Cancer Research Symposium 2018 in Seattle, Washington.

OvaCure was honoured to present at the 12th Biennial Ovarian Cancer Research Symposium in September at the University of Washington in Seattle.  

A keynote presentation by doctor Marie-Claire King, the first to identify the BRCA1, 3 days Symposium, over 370 participants, 4 sessions guiding us through the most important aspects of ovarian cancer: detection and prevention, genomics and molecular mechanism, tumor microenvironment and immunology, novel therapeutics- response and resistance.

Among others, OvaCure attended the panel "Role Of Advocates In Ovarian Cancer Research" and learned about the critical role of patient’s advocacy in securing funding.

Our sincerest thank you to the patients advocates for your great work! and thank you to Rivkin Center for Ovarian Cancer and the American Association for Cancer Research for giving us the precious chance to be part of this event and to help us reaching OvaCure's vision: curing ovarian cancer together.


Check the program of OvaCure Science Symposium 2018


“Immunotherapy and next-generation patient selection – unlocking the potential of personalized medicine”


17:00-18:00 RECEPTION: networking and light refreshments

18:00-18:10 Welcome by Kristin Parello-Plesner, OvaCure Strategic Director

“The importance of scientific progress from patient’s point of view – How do we see it?”

18:10-18:40 Prof. Inge Marie Svane, Chief Medical Officer, and Head of the Center for Cancer Immunotherapy, Herlev Hospital

“OvaCure T-cell Infusion Project – Where are we today and where are we heading?”

18:40-19:10 Dr. Mansoor Raza Mirza, M.D., Chief Oncologist at the Department of Oncology, Rigshospitalet

“OvaCure Tumour-Match Project. Combination of two breakthroughs in cancer: immunotherapy with a next-generation patient selection – How could it benefits patients?”

19:15 Networking and wrap up

The event is sponsored and endorsed by: 


1st OvaCure Science Symposium


Event Registration


Immunotherapy and Personalized Medicine for Ovarian Cancer Patients

Precision medicine will change the paradigm of cancer treatment. The only kind of treatment that has proven effective in later stage cancer with durable results is combination treatments that include immune therapy. However, identifying the successful treatment combination is challenging due to the low mutation frequency in this cancer and the variability observed patient to patient. OvaCure's portfolio projects contribute to almost all the immunotherapeutic approaches. With that synergetic approach, OvaCure strives to provide ovarian cancer patients with the best chance of survival.

The 1st Science Symposium is presented by OvaCure as our contribution to the International Ovarian Cancer Month. The goal of the Symposium is to bring together patients, foundations, philanthropists and members of the scientific, healthcare, pharmaceutical and precision medicine community; not only to increase disease awareness but to provide an overview of scientific advancement and describe the goals and achievements of some of our projects.

OvaCure is a Danish not-for-profit organization, also recognized as 501(c)(3) status in the USA, which strives to combine international efforts for curing ovarian cancer. In 4 years, OvaCure has started 5 ground-breaking projects and has 2 more in the pipeline - all of which have potential to cure and would not have existed otherwise. OvaCure also focuses on making a positive impression on society by promoting disease awareness through public outreach.


17:00-18:00 Networking and light refreshments

18:00-18:10 Welcome by Kristin Parello-Plesner, OvaCure Strategic Director

18:10-18:30 Prof. Inge Marie Svane, Chief Medical Officer, and Head of the Center for Cancer Immunotherapy, Herlev Hospital

“OvaCure T-cell Infusion Project – Where are we today and where are we heading?”

18:30-18:50 Dr. Mansoor Raza Mirza, Medical Director NSGO-CTU, Chief Oncologist at the Department of Oncology, Rigshospitalet

“OvaCure Tumour-Match Project. Combination of two breakthroughs in cancer: immune therapy with a next-generation patient selection – How could it benefits patients?”

18:50 Networking opportunity





Symbion, Fruebjergvej 3


OvaCure - Curing Ovarian Cancer Together



Bristol-Myers Squibb




Event Registration



OvaCure adopts new GDPR Policy

This privacy policy represents the policy adopted and followed by ovacure

Privacy and Cookies

OvaCure is committed to protecting your privacy. This policy explains how we collect and use the personal information you provide to us whether online or via phone, mobile, e-mail, letter or other correspondence. By using our website, any of our services, or providing us with any personal information we will assume you are agreeing to your information being used and disclosed in the ways described in this policy.



The EU General Data Protection Regulation (GDPR) effective from May 2018 gives all EU citizens more rights and protections for their personal data, to minimise the possibility of theft and fraud.

These regulations include provisions for the following areas:

  • The right to be informed: Organisations must publish a privacy notice, in addition to explaining transparently how they use this personal data.
  • The right of access: Individuals will have the right to demand details of any of their data that an organisation may hold. This information must be provided within one month of request at no charge to the individual.
  •  The right to rectification: If a person’s data is incorrect or incomplete, he or she has the right to have it corrected. If the organisation that holds the information has passed any of that information to third parties.  The company must inform the third party of the correction and inform the person which third parties have their personal data.
  • The right to be forgotten: A person may request the removal of his or her personal data in specific circumstances.
  • The right to restrict processing: Under certain circumstances, an individual can block the processing of his or her personal data.
  • The right to data portability: A person can access their data for their own use anywhere they prefer.
  • The right to object: A person can object to the use of their personal data for most purposes. We operate our Data protection in compliance with Danish law for personal data protection.
  • Specification for a personal information management system.

Our core principles regarding user privacy and data protection:

  • User privacy and data protection are inviolable human rights
  • We have a duty of care to people contained within our data
  • Data is a liability: it should only be collected and processed when absolutely necessary
  • We despise spam in all its forms
  • We will never sell, rent or otherwise distribute or make public any personal information


Relevant legislation

Alongside our business and internal computer systems, OvaCure’s website is designed to comply with the following national and international legislation with regards to data protection and user privacy:

·      Persondatabeskyttelsesloven, DK 2018

·      EU General Data Protection Regulation 2018 (GDPR)


This site’s compliance with the above legislation, all elements of which are stringent in nature, means that this site is likely compliant with the data protection and user privacy legislation set out by many other countries and territories as well. If you are unsure about whether this site is compliant with your own country of residences’ specific data protection and user privacy legislation you should contact our data protection officer (details of whom can be found in section 9.0 below) for clarification.


2. Data Protection Act

In carrying out our day to day activities we process and store personal information relating to our supporters and we are therefore required to adhere to the requirements of the Data Protection Act 1998. We take our responsibilities under this act very seriously and we ensure the personal information we obtain is held, used, transferred and otherwise processed in accordance with that Act and all other applicable data protection laws and regulations including, but not limited to, the Privacy and Electronic Communication Regulations.


3. This website collects and uses personal information for the following reason

This website collects and uses personal information for the following reasons:

3.1 Site visitation tracking

Like most websites, this site uses Google Analytics (GA) to track user interaction.

We use this data to determine the number of people using our site, to better understand how they find and use our web pages and to track their journey through the website.

Although GA records data such as your approximate geographical location, device, internet browser and operating system, none of this information personally identifies you to us.

A also records your computer’s IP address which could be used to personally identify you but Google do not grant us access to this. We consider Google to be a third party data processor (see section 6.0 below).

A makes use of cookies, details of which can be found on Google’s developer guides.

Disabling cookies on your internet browser will stop GA from tracking any part of your visit to pages within this website.


3.2 Forms

We use online forms to help you contact us, to receive donations an for our member to sign up. The information collected by these forms is send to us via email and stored in the website’s database, long enough to enable us to manage our processes.

If the form includes a payment, some information will be passed onto out third party data processors, mobile pay or Danske Bank (see section 4 below).

We delete any information when it is no longer needed.

3.3 Email newsletter

If you choose to join our newsletter mailings (which is sent via email), the email address that you submit to us will be stored in Mailchimp, which we use for our email marketing. We consider Mailchimp to be a third party data processor (see section 5 below). The email address that you submit will be stored within this website’s own database but not in any of our internal computer systems.

Your email address will remain within Mailchimp database on our website for as long as we continue to use this platform for email marketing or until you specifically request removal from the list.

You can do this by unsubscribing using the unsubscribe links contained in any email newsletters that we send you or by requesting removal via email. When requesting removal via email, please send your email to us using the email account that is subscribed to the mailing list.

Read more about Mailchimps policies here: https://kb.mailchimp.com/binaries/content/assets/mailchimpkb/us/en/pdfs/mailchimp_gdpr_sept2017.pdf


4. Credit, Debit card payment information

We use mobilepay in Denmark to process personal data on our behalf. The third parties we use are Mobile Pay and Danske Bank.

We do not retain any financial information you may submit as part of the purchasing process.

Mobile Pay monitor every transaction, 24/7 to prevent fraud, email phishing and identity theft. Every transaction is heavily guarded behind Mobile Pays advanced encryption. If something appears suspicious, their dedicated team of security specialists will identify suspicious activity and help protect you from fraudulent transactions.

our data as mentioned below is encrypted before transmission to prevent misuse of the transmitted data by third parties. SSL (Secure Socket Layer) is a security technology which guarantees that your personal data, including credit card information, login data and payment method, are securely transferred via the Internet. The data is encrypted so that is only readable by the Mobile Pay payment system.


5. Information sharing and disclosure

We will not sell or swap your information with any third party.

We may share your information with our data processors. These are trusted partner organisations that work with us in connection with our organisation’s purposes. All our trusted partners are required to comply with data protection laws and our high standards and are only allowed to process your information in strict compliance with our instructions. We will always make sure appropriate contracts and controls are in place and we regularly monitor all our partners to ensure their compliance.

We may disclose your personal information to third parties if we are required to do so through a legal obligation (for example to the police or a government body); to enable us to enforce or apply our terms and conditions or rights under an agreement; or to protect us, for example, in the case of suspected fraud or defamation.

We do not share your information for any other purposes.


6. The accuracy of your information

We aim to ensure that all information we hold about you is accurate and, where necessary, kept up to date. If any of the information we hold about you is inaccurate and either you advise us or we become otherwise aware, we will ensure it is amended and updated as soon as possible.


7. Storing your information

Although most of the information we store and process stays within the Denmark, some information may be transferred to countries outside the European Economic Area. This may occur if, for example, one of our trusted partners servers are located in a country outside the EU. These countries may not have similar data protection laws to the UK however, we will take steps with the aim of ensuring your privacy continues to be protected as outlined in this privacy policy.

We will keep your information for as long as required to enable us to operate our services but we will not keep your information for any longer than is necessary. We will take into consideration our legal obligations and tax and accounting rules when determining how long we should retain your information. When we no longer need to retain your information we will ensure it is securely disposed of, at the appropriate time.


8. Our website

Our website uses cookies to help it work well and to track information about how people are using it. More information on cookies can be found below.

For all areas of our website which collect personal information, we use a secure server. Although we cannot 100 per cent guarantee the security of any information you transmit to us, we enforce strict procedures and security features to protect your information and prevent unauthorised access.

Our website contains links to other websites belonging to third parties and we sometimes choose to participate in social networking sites including but not limited to You Tube and Facebook. We may also include content from sites such as these on our website however, would advise that we do not have any control the privacy practices of these other sites. You should make sure when you leave our site that you have read and understood that site’s privacy policy in addition to our own.


9. Cookies

What are cookies?

Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work better, as well as to provide information to the owners of the site. A cookie often contains a unique number, which can be used to recognise your computer when a user of your computer returns to a website that it visited previously.


How does OvaCure use cookies?

We use cookies to enhance the online experience of our visitors, to better understand how our websites are used (see Google Analytics above)


Your rights

Our cookies do not store financial information or information which is capable of directly identifying you (such as your name or address). You have the right to choose whether to accept these cookies. You can exercise this right by amending or setting the controls on your browser to reflect your cookie preferences. However, please note that if you choose to refuse cookies you may not be able to use the full functionality of this website.


Changing your cookie preferences

The “Help” menu in the toolbar of most web browsers will tell you how to change your browser’s cookie settings, including how to have the browser notify you when you receive a new cookie, and how to disable cookies altogether. An online guide is available if you have difficulties trying to change your browser settings.








Cookie terminology

We have classified our cookies into two broad types – ‘first party cookies’ and ‘third party cookies’:

We use Google Analytics cookies which help us monitor the site and improve it to make your experience better.

We also use some social media cookies which allow you to interact with our website through various social media sites such as Facebook, Twitter, instagram and You Tube.

Our content management system will also set cookies without which the site could not function.

In addition, cookies may be either ‘session cookies’ or ‘persistent cookies’. Your computer automatically removes session cookies once you close your browser. Persistent cookies will survive on your computer until an expiry date specified in the cookie itself, is reached.

We do not use third party cookies that track your usage of this and other websites to serve advertising.


10. Data breaches

In the event of a breach of security leading to the accidental or unlawful destruction, loss, alteration, unauthorised disclosure of, or access to, personal data, the orgainsation shall promptly assess the risk to people’s rights and freedoms and if appropriate report this breach to the Danish Authorities.


11. Changes to the policy

This policy replaces all previous versions and is correct as of the date at the end of this web page. We will regularly review and update this Privacy and Data Protection Statement and will update, modify, add or remove sections at our discretion.  Any changes will be notified to you through on this page. Your continued use of our website, any of our services and/or the continued provision of personal information after we have posted the changes to these terms will be taken to mean you are in agreement with those changes.


12. Your rights

You have the right to:

·      request a copy of the information we hold about you;

·      update or amend the information we hold about you if it is wrong;

·      change your communication preferences at any time;

·      ask us to remove your personal information from our records;

·      object to the processing of your information for marketing purposes; or

·      raise a concern or complaint about the way in which your information is being used.

·      If you wish to find out more about these rights, or obtain a copy of the information we hold about you, please contact our Data Controller / us at:


Fruebjergvej 3

2100 Østerbro, Copenhagen



Telephone:  01273 234033


Email:  office@ovacure.org


13. Privacy queries

If you have any questions or queries about this Privacy and Data Protection Statement, please contact our Data Protection Officer / Data Controller using the above address and contact details

The OvaCure Foundation is now a 501(c)3 non-profit, tax-exempt charity in the USA!

Screenshot 2017-09-26 13.08.27.png

To change the game of ovarian cancer research - we have to go global!

OvaCure is pleased to announce our new non-profit US organisation status as a 501(c)3 tax exempt charity based on a letter of confirmation from the US Internal Revenue Service dated 18th July 2017. The OvaCure Foundation will function as our new US entity which will bridge our work across the pond. This status will help us accomplish our goals by engaging in new partnership building and US-based fundraising.

All US donations to the OvaCure Foundation are tax deductible and are 100% directed to our breakthrough, in-patient, clinical trial projects.